Mednet Logo
HomeHematologyQuestion

Based on recent data would you consider adding ATRA to low dose rituximab for steroid refractory ITP?

1 Answers
Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Weill Medical College of Cornell University

This is hard to answer in the absence of much more information about the patient. In a steroid refractory patient, it is important to understand why. This puts the patient immediately into a meeting refractory group (not responding to steroids). If there is an immediate need, IVIG is better. If the ...

Register or Sign In to see full answer